Pons-Fuster, Eduardo; González-Ponce, Celia-María; Ros-Martínez, Silverio; Fernández-Ávila, Juan-José; Díaz-Carrasco, María-Sacramento; Espuny-Miro, Alberto
(SPRINGER, 2025-12)
BACKGROUND: Metastatic hormone-sensitive prostate cancer (mHSPC) is an aggressive disease with a poor prognosis. Current treatment guidelines recommend combining androgen receptor axis-targeted therapies (ARATs) with ...